Loyola’s Institute for Investor Protection is the grateful recipient of a cy pres distribution from In re China Medicine Securities Litigation.
Loyola's Institute for Investor Protection (“IIP”) is a non-partisan, independent academic center that promotes investor protection for the individual consumer and the public. We seek to shape policy issues affecting investors.
Investors are protected by securities laws governing their investment decisions. These laws require the disclosure of relevant information. Our goal is to educate investors about the private remedies Congress and the judiciary envisioned would deter disclosure violations and make aggrieved investors whole.